(Q55383454)

5 July 2018

title

Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience. (English)

1 reference

5 July 2018

0 references

1 reference

Jihye Park

1

1 reference

5 July 2018

Jae Hee Cheon

2

1 reference

5 July 2018

Yehyun Park

3

1 reference

5 July 2018

Soo Jung Park

4

1 reference

5 July 2018

Tae Il Kim

5

1 reference

5 July 2018

Won Ho Kim

6

1 reference

5 July 2018

publication date

30 April 2018

1 reference

5 July 2018

published in

Intestinal research

1 reference

5 July 2018

volume

16

1 reference

5 July 2018

issue

2

1 reference

5 July 2018

page(s)

315-318

1 reference

5 July 2018

Creative Commons Attribution-NonCommercial 4.0 International

copyright license

start time

1 January 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Gastrointestinal Behçet's disease: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5934607

Safety of infliximab for the treatment of inflammatory bowel disease: current understanding of the potential for serious adverse events

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5934607

An update on the diagnosis, treatment, and prognosis of intestinal Behçet's disease

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5934607

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5934607

Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5934607

Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet's disease

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5934607

Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5934607

6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease

12 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29743847

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[The frequency and the course of the adverse effects of azathioprine/6-mercaptopurine treatment in patients with inflammatory bowel disease]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29743847

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.5217/IR.2018.16.2.315

1 reference

5 July 2018

PMCID

5934607

1 reference

5 July 2018

PubMed ID

29743847

1 reference

5 July 2018